Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

NOREPINEPHRINE IN BLOOD VESSELS: CONCENTRATION, BINDING, UPTAKE AND DEPLETION

BARRY A. BERKOWITZ, JAMES H. TARVER and SYDNEY SPECTOR
Journal of Pharmacology and Experimental Therapeutics April 1971, 177 (1) 119-126;
BARRY A. BERKOWITZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAMES H. TARVER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SYDNEY SPECTOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Appreciable concentrations of norepinephrine were found in the blood vessels of the rat, rabbit and guinea pig. Rat aorta had the lowest concentration of norepinephrine (0.4 µg/g), the guinea-pig and rabbit aorta had higher levels, 1 to 2 µg/g. The content in the mesenteric and renal arteries, the vena cava and mesenteric vein exceeded 1.5 µg/g. An uneven regional distribution was noted; the distal portions of the aorta and mesenteric artery had twice the content of the proximal tissue. After inhibition of the enzyme monoamine oxidase, the rat mesenteric artery and vein retained large amounts of norepinephrine whereas the aorta and heart did not, suggesting a relative absence of binding sites in the rat heart and aorta as compared to the mesenteric bed. Since blood vessels extracted less than one-fourth as much norepinephrine-3H from the circulation as the heart, it is possible that in the vasculature the reuptake mechanism may play an auxiliary role in the disposition of norepinephrine. Reserpine (1.5 mg/kg) decreased the content of norepinephrine throughout the cardiovascular system, depleting the heart to the greatest extent.

Footnotes

    • Received June 24, 1970.
    • Accepted November 22, 1970.
  • © 1971, by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 177, Issue 1
1 Apr 1971
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
NOREPINEPHRINE IN BLOOD VESSELS: CONCENTRATION, BINDING, UPTAKE AND DEPLETION
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

NOREPINEPHRINE IN BLOOD VESSELS: CONCENTRATION, BINDING, UPTAKE AND DEPLETION

BARRY A. BERKOWITZ, JAMES H. TARVER and SYDNEY SPECTOR
Journal of Pharmacology and Experimental Therapeutics April 1, 1971, 177 (1) 119-126;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

NOREPINEPHRINE IN BLOOD VESSELS: CONCENTRATION, BINDING, UPTAKE AND DEPLETION

BARRY A. BERKOWITZ, JAMES H. TARVER and SYDNEY SPECTOR
Journal of Pharmacology and Experimental Therapeutics April 1, 1971, 177 (1) 119-126;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

Article

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels
  • Ethanol-Induced Barrier Dysfunction and Its Prevention by Growth Factors in Human Intestinal Monolayers: Evidence for Oxidative and Cytoskeletal Mechanisms
Show more Article

Articles

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels
  • Ethanol-Induced Barrier Dysfunction and Its Prevention by Growth Factors in Human Intestinal Monolayers: Evidence for Oxidative and Cytoskeletal Mechanisms
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics